Matthew Johnson
About Matthew Johnson
Matthew Johnson is a Senior Group Leader at the Broad Institute of MIT and Harvard, specializing in genetic and genomic techniques for central nervous system disorders. He has extensive experience in neuroscience research, having held various positions at prestigious institutions including Harvard Medical School and Stanford University.
Current Position at Broad Institute
Matthew Johnson serves as a Senior Group Leader at the Broad Institute of MIT and Harvard. He has held this position since 2023. In this role, he leads research initiatives focused on understanding and treating central nervous system disorders, leveraging his extensive background in genetic and genomic techniques.
Previous Roles at Broad Institute
Matthew Johnson has a significant history at the Broad Institute of MIT and Harvard, where he worked as a Research Scientist from 2017 to 2023 and as a Research Scientist II from 2019 to 2023. His contributions during these years were instrumental in advancing research related to human brain development and disease.
Educational Background
Matthew Johnson earned a Bachelor of Science degree in neuroscience from Brown University, where he studied from 1998 to 2002. He later pursued a PhD in Neurobiology at Yale University, completing his studies from 2004 to 2009. This educational foundation has equipped him with the knowledge and skills necessary for his research career.
Research Experience
Matthew Johnson has extensive research experience, including a role as a Postdoctoral Research Fellow at Boston Children's Hospital from 2010 to 2017. He also worked at Harvard Medical School as an Instructor for one year from 2016 to 2017. His research expertise encompasses the integration of genetic and genomic techniques to enhance the understanding of central nervous system disorders.
Professional History
Matthew Johnson's professional history includes various research positions at prestigious institutions. He served as a Research Assistant at Stanford University from 2002 to 2004 and as a graduate student at Yale School of Medicine from 2004 to 2009. He also held a position as a Research Specialist II and III at the Howard Hughes Medical Institute from 2019 to 2023.